论文信息 - Subcutaneous injection of infliximab CT‐P13 results in stable drug levels within 14‐day treatment cycle in Crohn’s disease - 字舞流文

Subcutaneous injection of infliximab CT‐P13 results in stable drug levels within 14‐day treatment cycle in Crohn’s disease

B. Flourié | L. Waeckel | X. Roblin | P. Veyrard | S. Nancey | A. Berger | S. Paul | M. Barrau | L. Bastide | Anne-Sophie Paucelle | Sany Kwiatek